Jitendra Patil

Jitendra Patil has a diverse work experience in the pharmaceutical industry. Jitendra started their career as a Jr. Executive at Meyer Vitabiotics in 2010 and then progressed to roles as an Executive and Senior Executive in Medical Services. Jitendra was responsible for designing formulations, conducting literature research, and responding to product-based queries based on clinical studies.

In 2013, Jitendra joined Akumentis Healthcare Ltd as an Asst. Manager in Medical Services, where they continued with similar responsibilities. Jitendra later became the Medical Services Manager, focusing on designing formulations, conducting literature research, and replying to product-based queries.

In 2017, Jitendra joined Oaknet Healthcare Private Ltd. as a Senior Manager Medico Marketing, where they gained experience in medico marketing. After two years, they joined USV PRIVATE LIMITED as a Group Product Manager, specializing in diabetes products.

Jitendra's next role was at Oaknet Healthcare Pvt. Ltd. as a Deputy Marketing Manager in Dermatology & Cosmetology. Jitendra then moved to Emcure Pharmaceuticals Limited in 2022 as the Head of Marketing, where they led the marketing department.

As of 2023, Jitendra Patil is currently working as the Head of Marketing for the Ipca BIONOVA team at Ipca Laboratories Limited.

Jitendra Patil completed their Master's Degree in M.Pharma (Pharmacology) from North Maharashtra University, from 2007 to 2009. Jitendra also took the Graduate Aptitude Test in Engineering (GATE) in Pharmaceutical Sciences at the Indian Institute of Technology, Kanpur in 2007. Jitendra obtained their Bachelor's Degree in B. Pharmacy from R.C.Patel College of Pharmacy, Shirpur, NMU, Maharashtra, from 2003 to 2007. Before that, they completed their 12th grade at R.C.Patel Junior College, Shirpur, Maharashtra, in Biology/Biological Sciences, General, from 2002 to 2003. Jitendra's education began at R.C.Patel Secondary School, Shirpur, Maharashtra, where they completed their High School education in 2000.